PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 96 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $302,000 | -23.5% | 83,500 | -28.0% | 0.04% | -31.4% |
| Q3 2019 | $395,000 | -27.5% | 116,000 | 0.0% | 0.05% | +34.2% |
| Q2 2019 | $545,000 | -44.3% | 116,000 | -60.3% | 0.04% | -15.6% |
| Q1 2019 | $979,000 | +2.2% | 292,500 | -18.8% | 0.04% | -31.8% |
| Q4 2018 | $958,000 | +24.3% | 360,343 | +161.6% | 0.07% | +50.0% |
| Q3 2018 | $771,000 | -18.1% | 137,748 | -25.8% | 0.04% | -20.0% |
| Q2 2018 | $941,000 | +1263.8% | 185,700 | +514.9% | 0.06% | +511.1% |
| Q4 2015 | $69,000 | – | 30,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |